GlobeNewswire

VSBLTY JOINS CYBER OPS ALLIANCE, DELIVERING SECURITY SOFTWARE SOLUTIONS UTILIZING ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING

Share

Philadelphia, PA, May 09, 2019 (GLOBE NEWSWIRE) -- VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt: 5VS) (OTC:VSBGF), a leading software technology company, has joined the Cyber Ops Alliance (COA), a major international cyber security integrator, according to a joint announcement today by Dan Downing, COA CEO, and Jay Hutton, VSBLTY Co-founder & CEO.

A consortium of best-in-class cyber security specialists, COA was founded by former intelligence community executives, decorated military general officers, senior law enforcement directors and the world’s best subject matter experts on Darknet operations. Each company in the Alliance brings unique capabilities and operates as part of a COA team with a clear, coordinated focus.

COA member solutions are in use in various deployments including Federal law enforcement agencies, large philanthropic institutions, a global private security firm and numerous state fusion centers, which provide resources, expertise and information to maximize the ability to detect, prevent, investigate and respond to criminal and terrorist activities. 

In making the announcement, Downing said, “We are excited that VSBLTY’s leading-edge technology can now be combined with the advanced security capabilities of other COA companies. Wherever deployed, VSBLTY can provide perimeter security by looking for ‘persons of interest’ or by identifying objects—including weapons—in real time.”

VSBLTY Vector™ is cutting-edge software technology that uses artificial intelligence and machine learning to—in milliseconds—identify individuals from a pre-loaded database as well as any type of weapon.

Hutton added, “With more and more so-called soft targets being attacked around the world, heightened security is needed virtually everywhere, and innovative technologies are needed to do that. In most instances, our face on cameras provide better facial recognition than overhead CCTV cameras to enable faster, professional security responses to threats. As part of the COA, we are advancing the increasingly important ability to provide security where it has never been available before.”

Investor Relations

MarketSmart Communications Inc.,+1-877-261-4466
info@marketsmart.ca

 
CONTACT: Linda Rosanio, 609-472-0877           
lrosanio@vsblty.net

 
About VSBLTY (www.vsblty.net)

Headquartered in Philadelphia, VSBLTY (CSE: VSBY) (Frankfurt: 5VS) (OTC:VSBGF) is the world leader in Proactive Digital Display™, which transforms retail and public spaces as well as place-based media networks with SaaS-based audience measurement and security software that uses artificial intelligence and machine learning. 

 
CONTACT: Dan Downing
dan.downing@advantagefactory.com

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Oboya får en viktig order i USA20.8.2019 09:31:00 CESTPressemelding

Oboya Horticulture Industries AB (publ) (”Oboya”) har genom sitt helägda dotterbolag Oboya Metal Qingdao Co. Ltd i Qingdao, Kina fått en order från befintlig kund i USA. Ordervärdet uppgår till ca 0,37 MUSD, motsvarande ca 3,59 MSEK. Ordern avser leverans av blomstervagnar och kommer att levereras från september och fram till oktober 2019. Ordervärdet uppgår till 0,37 MUSD, motsvarande ca 3,59 MSEK. Den befintliga kunden är ett av de ledande logistik-, transport- och serviceföretagen inom odlingsindustrin i Nordamerika. Blomstervagnarna kommer att användas för såväl effektiv transport som för exponering av växter eller blommor i butik. "Det är glädjande att det finns fortsatt efterfrågan på Oboyas produkter i USA, trots nuvarande handelskonflikt mellan Kina och USA. Vi kommer att fortsätta att etablera oss på marknaden och därigenom successivt öka våra marknadsandelar globalt på sikt”, säger Robert Wu, VD för Oboya Horticulture Industries AB. Erik Penser Bank AB är Oboyas Certified Adv

Oboya receives an important order in USA20.8.2019 09:31:00 CESTPress release

Oboya Horticulture Industries AB (publ) ("Oboya") has through its wholly owned subsidiary Oboya Metal Qingdao Co. Ltd. in Qingdao, China received an order from an existing customer in the United States. The order value amounted to approximately USD 0.37 million, corresponding to approximately SEK 3.59 million. The order concerns delivery of flower trolleys and will be delivered from September until October 2019. The order value amounts to USD 0.37 million, corresponding to approximately SEK 3.59 million. The existing customer is one of the leading logistics, transport and service companies in the cultivation industry in North America. The flower trolleys will be used for efficient transport as well as for the exposure of plants or flowers in stores. "It is gratifying that there is continued demand for Oboya's products in the US, despite the current trade conflict between China and the US. We will continue to establish ourselves in the market and thereby gradually increase our market sh

Conditions for sale of Riksbank certificates20.8.2019 09:30:00 CESTPress release

AUCTION DATE: AUG 20, 2019 START DATE: AUG 21, 2019 MATURITY DATE: AUG 28, 2019 NOMINAL AMOUNT: 414.0 BLN FIXED RATE: -0.25 % ALL MONETARY POLICY COUNTERPARTIES ARE INVITED TO SUBMIT BIDS TO THE RIKSBANK (08-6966970) BY 10.00 AM ON AUG 20, 2019, AT THE LATEST. CONFIRMATION OF BIDS TO E-MAIL: RBCERT@riksbank.se THE LOWEST ACCEPTED BID VOLUME IS SEK 1 MLN. THE HIGHEST ACCEPTED BID VOLUME IS SEK 414.0 BLN. RESULT OF AUCTION WILL BE PUBLISHED AT 10.15 (CET/CEST) ON AUG 20, 2019. COMPLETE TERMS AND CONDITIONS CAN BE RETRIEVED AT WWW.RIKSBANK.SE

Karolinska Development's portfolio company Forendo Pharma commences Phase 1b study of its drug candidate FOR-621920.8.2019 09:00:00 CESTPressemelding

STOCKHOLM – August 20, 2019. Karolinska Development (Nasdaq Stockholm: KDEV) announces today that its portfolio company Forendo Pharma has initiated dosing in a Phase 1b clinical study with the aim to demonstrate Proof of Mechanism for FOR-6219 – a drug candidate intended for the treatment of endometriosis. Endometriosis is a chronic condition that affects up to 10 per cent of women in reproductive age and causes repeated pain symptoms, infertility and impaired quality of life. Currently available treatments have limitations in efficacy or cause harmful side effects due to estrogen depletion. FOR-6219 is a HSD17B1 inhibitor aiming to reduce estrogen production locally in the endometriosis lesions. In the Phase 1b study, FOR-6219 will be administered to healthy premenopausal women to explore its effect on the endometrium by measuring changes in endometrial thickness and endometrial estrogen levels. In addition to these local effects, systemic hormone levels will be measured. The study w

Karolinska Development's portfolio company Forendo Pharma commences Phase 1b study of its drug candidate FOR-621920.8.2019 09:00:00 CESTPress release

STOCKHOLM – August 20, 2019. Karolinska Development (Nasdaq Stockholm: KDEV) announces today that its portfolio company Forendo Pharma has initiated dosing in a Phase 1b clinical study with the aim to demonstrate Proof of Mechanism for FOR-6219 – a drug candidate intended for the treatment of endometriosis. Endometriosis is a chronic condition that affects up to 10 per cent of women in reproductive age and causes repeated pain symptoms, infertility and impaired quality of life. Currently available treatments have limitations in efficacy or cause harmful side effects due to estrogen depletion. FOR-6219 is a HSD17B1 inhibitor aiming to reduce estrogen production locally in the endometriosis lesions. In the Phase 1b study, FOR-6219 will be administered to healthy premenopausal women to explore its effect on the endometrium by measuring changes in endometrial thickness and endometrial estrogen levels. In addition to these local effects, systemic hormone levels will be measured. The study w

Nexstim reports good initial results on the use of Smartfocus® technology in treatment of major depressive disorder20.8.2019 09:00:00 CESTPress release

Press Release, Helsinki, 20 August 2019 at 10.00 am (EET) Nexstim reports good initial results on the use of Smartfocus ® technology in treatment of major depressive disorder Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") – the company developing and marketing a unique brain stimulation technology for personalized treatment of major depressive disorder (MDD) – announces that the first white paper about the initial experiences of its NBT® system with SmartFocus® technology in treatment of MDD has been published. The white paper is published by Island Psychiatry PC, a New York -based TMS therapy provider and Nexstim. It reports the experiences in the first 10 consecutive patients completing treatment of MDD with Nexstim NBT® system at Island Psychiatry’s clinic. The treatment outcomes of these 10 adult patients were good. 50 % of the patients were in remission at the end of the treatment while 70 % had obtained a clinical response rate. These patient-reported outcomes are hi